Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome

Pim B van der Meer; Linda Dirven; Marta Fiocco; Martin Jb Taphoorn; Johan Af Koekkoek

doi:10.2217/cns-2020-0009

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome

CNS Oncol. 2020 Jun;9(2):CNS53. doi: 10.2217/cns-2020-0009. Epub 2020 Jun 30.

Authors

Pim B van der Meer¹, Linda Dirven^{1

2}, Marta Fiocco^{3

4}, Martin Jb Taphoorn^{1

2}, Johan Af Koekkoek^{1

2}

Affiliations

¹ Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
³ Department of Biomedical Data Sciences, Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.
⁴ Mathematical Institute, Leiden University, Leiden, The Netherlands.

No abstract available

Keywords: anticonvulsants; antiepileptic drugs; brain tumor; glioma; lacosamide; levetiracetam; pregabalin; retention rates; seizures; treatment failure.

Publication types

Editorial

MeSH terms

Anticonvulsants / therapeutic use*
Brain Neoplasms / complications
Brain Neoplasms / drug therapy*
Glioma / complications
Glioma / drug therapy*
Humans
Seizures / drug therapy*
Seizures / etiology
Treatment Outcome

Substances

Anticonvulsants